Kanghua Biological (300841.SZ) released its performance for the first three quarters, with a net profit attributable to the parent company of 227 million yuan, a year-on-year increase of 20.18%.

Zhitong Finance APP News, Kanghua Biological (300841.SZ) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 885 million yuan, a year-on-year increase of 5.31%; net profit attributable to shareholders of the listed company was 227 million yuan, a year-on-year increase of 20.18%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 216 million yuan, a year-on-year increase of 17.86%; basic earnings per share were 1.7489 yuan.